Elsevier’s Oncology Journal Network highlights

Annals of Oncology

• Updated treatment recommendations for systemic treatment: from the ESMO Metastatic Breast Cancer Living Guideline

• Prediction of survival after de-escalated neoadjuvant therapy in HER2+ early breast cancer: A pooled analysis of three WSG trials

Cancer Letters

• Autophagy-driven regulation of cisplatin response in human cancers: Exploring molecular and cell death dynamics

Cancer Pathogenesis and Therapy

• Biomarkers, isolation methods, and therapeutic implications of breast cancer stem cells

• Breast cancer risk associated with BRCA1 and BRCA2 pathogenic variants in the Eastern Chinese population

Cancer Treatment and Research Communications

• Cardiotoxicity in breast cancer treatment: Causes and mitigation

Cancer Treatment Reviews

• Ovarian escape in premenopausal breast cancer: Challenges and strategies for optimizing hormone suppression

• Overcoming Resistance to CDK4/6 inhibitors in Hormone Receptor positive, HER2 negative breast cancer: Innovative Combinations and Emerging Strategies

Clinical Breast Cancer

• The Role of Immunotherapy in Triple-Negative Breast Cancer (TNBC)

• Metaplastic Breast Cancer: Current Understanding and Future Directions

Clinical Oncology

• Ten-Year Outcomes of Stereotactic Body Radiotherapy for Oligometastatic Breast Cancer: Does Synchronous Oligometastatic Breast Cancer Benefit?

Clinical Surgical Oncology

• Outpatient revisits associated with three sentinel lymph node detection techniques for breast cancer: A propensity score weighted analysis

• Confirmation of the importance of lymphatic leakage in the formation of axillary fluid collections after lymph node dissection for breast cancer

Current Problems in Cancer: Case Reports

• ML: Early Breast Cancer Diagnosis

Current Problems in Cancer

• Imaging of breast cancer–beyond the basics

European Journal of Cancer

• Comparison of hypofractionation and conventional fractionation in postmastectomy radiotherapy after immediate breast reconstruction: A systematic review and meta-analysis of complications

• Diagnostic performance of axillary ultrasound after neoadjuvant chemotherapy in initially node-positive breast cancer patients – Results from the prospective AXSANA registry trial

ESMO Open

• Impact of the Prosigna assay on neoadjuvant treatment decision-making in patients with early-stage HR-positive/HER2-negative breast cancer: a single-center prospective observational study

• Effectiveness of post-trastuzumab deruxtecan treatments and incidence of interstitial lung disease in HER2-positive metastatic breast cancer: a real-world, observational cohort study

ESMO Rare Cancers

• Molecular pathobiology of breast fibroepithelial tumours

ESMO Real World Data and Digital Oncology

• Treatment toxicities and pathological response through the evolution of neoadjuvant regimens in early triple-negative breast cancer

• Association between neoadjuvant paclitaxel dose intensity and outcomes in early triple-negative and HER2-positive breast cancer: a real-world data analysis

International Journal of Particle Therapy

• Cardiac Substructure Dose Reduction and Toxicity Risk Assessment: IMPT Versus IMRT for Breast Cancer

• NTCP-Based Prediction of Lung Sparing With IMPT in BC Patients and Implication of Patient Selection

• Dose Constraints in Carbon-Ion Radiation Therapy to Minimize the Risk of Pectoral Myositis

International Journal of Radiation Oncology, Biology, Physics

• Beyond Technology: The Impact of Personal Physics Consultation on Patient Anxiety in Breast Cancer Radiotherapy

• HYPofractionated Adjuvant RadioTherapy in 1 versus 2 weeks in high-risk patients with breast cancer (HYPART): Acute toxicity results.

Journal of the National Cancer Center

• Real-world effectiveness of goserelin 10.8-mg compared to goserelin 3.6-mg in premenopausal and perimenopausal Chinese patients with hormone receptor positive breast cancer: a cohort study

• Guidelines for diagnosis and treatment of advanced breast cancer in China (2022 edition)

Magnetic Resonance Imaging

• Prediction of HER-2 expression status in breast cancer based on multi-parameter MRI intratumoral and peritumoral radiomics

• Study on predicting breast cancer Ki-67 expression using a combination of radiomics and deep learning based on multiparametric MRI

Neoplasia

• Integration of bioinformatics and machine learning strategies identifies APM-related gene signatures to predict clinical outcomes and therapeutic responses for breast cancer patients

Oral Oncology

• Precision medicine in Salivary Gland Carcinoma: Insights from breast and prostate cancer

Practical Radiation Oncology

• Favorable Rates of Excellent or Good Cosmetic Outcomes in Patients Treated With Carefully Planned Accelerated Partial Breast Irradiation Delivered Twice Daily or Once Every Other Day

• "The Efficacy and Toxicity of Hypofractionated Regional Nodal Irradiation in Breast Cancer Patients"

Radiation Medicine and Protection

• A review of therapeutic agents for breast cancer with potentially radiosensitizing properties

Radiotherapy and Oncology

• What guides regional nodal irradiation in node positive breast cancer following upfront sentinel lymph node biopsy?

• Five-year trends and baseline predictors of patient-reported adverse events following breast radiotherapy with a boost in the IMPORT HIGH phase III randomised controlled trial

Seminars in Oncology

• Breast cancer exosomes: Managing macrophage polarization and immune regulation in the tumor microenvironment

• A 3-miRNA signature for noninvasive breast cancer detection

Seminars in Ultrasound, CT, and MRI

• The Current State of Timeliness in the Breast Cancer Diagnosis Journey: Abnormal Screening to Biopsy

Surgical Oncology

• Breast Cancer-Related Lymphedema: A Critical Review on Recent Progress

• The accuracy of MRI in detecting pathological complete response following neoadjuvant chemotherapy in different breast cancer subtypes

The Breast

• Physicians’ knowledge, practice, and attitudes on fertility and pregnancy-related issues in young women with advanced breast cancer: results of the ABC6 and ABC7 survey

• Expert consensus on treating HR+/HER2- metastatic breast cancer based on real-world practice patterns observed in the RETRACT survey of US oncologists

Translational Oncology

• Natural flavonoids exhibit potent anticancer activity by targeting microRNAs in cancer: A signature step hinting towards clinical perfection

Elsevier’s Oncology Journal Network